/
AbCellera Biologics Inc.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
Mentions
4 mentions · latest on 30 Sept 2026
See which tracked investors hold AbCellera Biologics Inc. →Ownership and position changes on OwnershipTrace
| Life Extension per Token | - | 30 Sept 2026 | |
| Abcellera, AST Spacemobile and RocketLab Q2 2026 ER Digest | - | 23 Sept 2026 | |
| Healthcare & Biotech is Inflecting: LLY, TEM, ABCL (Part 1) | - | 16 Jul 2026 | |
| Value Hive PodcastPodcast | Peter Mantas: The Biotech Bubble Whisperer | - | 19 Jun 2026 |